Studies on serum requirements for the cultivation of Plasmodium falciparum. 1. Animal sera.

PubWeight™: 0.94‹?› | Rank: Top 15%

🔗 View Article (PMC 2536078)

Published in Bull World Health Organ on January 01, 1982

Authors

A A Divo, J B Jensen

Articles by these authors

Human malaria parasites in continuous culture. Science (1976) 59.70

Plasmodium falciparum in culture: use of outdated erthrocytes and description of the candle jar method. J Parasitol (1977) 4.48

Concentration from continuous culture of erythrocytes infected with trophozoites and schizonts of Plasmodium falciparum. Am J Trop Med Hyg (1978) 3.46

Plasmodium falciparum in culture: establishment of additional strains. Am J Trop Med Hyg (1978) 2.85

Fine structure of human malaria in vitro. J Protozool (1978) 2.32

Plasmodium falciparum strain-specific antibody blocks binding of infected erythrocytes to amelanotic melanoma cells. Nature (1983) 2.32

Association between human serum-induced crisis forms in cultured Plasmodium falciparum and clinical immunity to malaria in Sudan. Infect Immun (1983) 2.08

Nutritional requirements of Plasmodium falciparum in culture. I. Exogenously supplied dialyzable components necessary for continuous growth. J Protozool (1985) 1.91

Oxygen- and time-dependent effects of antibiotics and selected mitochondrial inhibitors on Plasmodium falciparum in culture. Antimicrob Agents Chemother (1985) 1.77

Stage-dependent effects of chloroquine on Plasmodium falciparum in vitro. J Protozool (1983) 1.70

Induction of crisis forms in cultured Plasmodium falciparum with human immune serum from Sudan. Science (1982) 1.57

Uptake of [3H]chloroquine by drug-sensitive and -resistant strains of the human malaria parasite Plasmodium falciparum. Biochem Pharmacol (1986) 1.53

Stage specific actions of antimalarial drugs on Plasmodium falciparum in culture. Am J Trop Med Hyg (1989) 1.51

Transient depletion of T cells with high LFA-1 expression from peripheral circulation during acute Plasmodium falciparum malaria. Eur J Immunol (1991) 1.44

Evidence of endothelial inflammation, T cell activation, and T cell reallocation in uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg (1994) 1.42

Agglutination of Plasmodium falciparum-infected erythrocytes from east and west African isolates by human sera from distant geographic regions. Am J Trop Med Hyg (1992) 1.41

[Episodic hypoxemia and coinciding ECG changes after acute myocardial infarction]. Ugeskr Laeger (1995) 1.37

Effects of antibiotics on Plasmodium falciparum in vitro. Am J Trop Med Hyg (1983) 1.35

Development of the mesencephalic dopaminergic neuron system is compromised in the absence of neurogenin 2. Development (2006) 1.33

Continuous culture of Plasmodium falciparum: its impact on malaria research. Int J Parasitol (1997) 1.28

Comparison of immunity to malaria in Sudan and Indonesia: crisis-form versus merozoite-invasion inhibition. Proc Natl Acad Sci U S A (1984) 1.28

Immunization against malaria with antigen from Plasmodium falciparum cultivated in vitro. Proc Natl Acad Sci U S A (1978) 1.27

The mitochondrion of Plasmodium falciparum visualized by rhodamine 123 fluorescence. J Protozool (1985) 1.27

Increased plasma levels of soluble ICAM-1 and ELAM-1 (E-selectin) during acute Plasmodium falciparum malaria. Immunol Lett (1993) 1.25

Potential antimalarial candidates from African plants: and in vitro approach using Plasmodium falciparum. J Ethnopharmacol (1986) 1.24

Mitogenic activity of extracts from continuous cultures of Plasmodium falciparum. Am J Trop Med Hyg (1982) 1.20

Cultivation of erythrocytic stages. Bull World Health Organ (1977) 1.20

An in vitro assay system for the identification of potential antimalarial drugs. J Parasitol (1983) 1.20

Plasmodium falciparum: rapid assay for in vitro inhibition due to human serum from residents of malarious areas. Exp Parasitol (1982) 1.18

Loss of cellular immune reactivity during acute Plasmodium falciparum malaria. FEMS Microbiol Immunol (1991) 1.15

Lack of cross-resistance to 4-aminoquinolines in chloroquine-resistant Plasmodium falciparum in vitro. J Parasitol (1983) 1.13

Observations on gametogenesis in Plasmodium falciparum from continuous culture. J Protozool (1979) 1.13

Possible secretory function of the rhoptries of Eimeria magna during penetration of cultured cells. J Parasitol (1976) 1.11

Longitudinal study on the in vitro immune response to Plasmodium falciparum in Sudan. Infect Immun (1984) 1.10

Soluble Plasmodium falciparum antigens contain carbohydrate moieties important for immune reactivity. J Clin Microbiol (1987) 1.09

Effects of mitochondrial inhibitors on intraerythrocytic Plasmodium falciparum in in vitro cultures. J Protozool (1986) 1.09

Comparison of inducers of crisis forms in Plasmodium falciparum in vitro. Am J Trop Med Hyg (1985) 1.08

Making the most of Papua New Guinea's biodiversity: Establishment of an integrated set of programs that link botanical survey with pharmacological assessment in "The Land of the Unexpected" Pharm Biol (2009) 1.08

Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer. J Clin Oncol (1990) 1.06

Ultrastructure of the invasion of Eimeria magna sporozoites into cultured cells. J Protozool (1975) 1.05

High proportion of subclinical Plasmodium falciparum infections in an area of seasonal and unstable malaria in Sudan. Am J Trop Med Hyg (1995) 1.04

Synthesis and evaluation of 1,2,2-tris(sulfonyl)hydrazines as antineoplastic and trypanocidal agents. J Med Chem (1990) 1.04

Cell-mediated immune responses to Plasmodium falciparum purified soluble antigens in sickle-cell trait subjects. Immunol Lett (1990) 1.00

Appearance of nephritis associated with type 57 streptococcal impetigo in North America. N Engl J Med (1970) 0.99

Antibody responses to Rhoptry-Associated Protein-1 (RAP-1) of Plasmodium falciparum parasites in humans from areas of different malaria endemicity. Parasite Immunol (1997) 0.98

Clinical drug-resistant falciparum malaria acquired from cultured parasites. Am J Trop Med Hyg (1981) 0.96

Nutritional requirements of Plasmodium falciparum in culture. III. Further observations on essential nutrients and antimetabolites. J Protozool (1985) 0.95

Kinetic modelling of the response of Plasmodium falciparum to chloroquine and its experimental testing in vitro. Implications for mechanism of action of and resistance to the drug. Biochem Pharmacol (1990) 0.94

Activity of quinoline-containing antimalarials against chloroquine-sensitive and -resistant strains of Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg (1987) 0.92

A histidine-rich protein from Plasmodium falciparum and its interaction with membranes. Bull World Health Organ (1977) 0.90

Identification of an erythrocyte binding peptide from the erythrocyte binding antigen, EBA-175, which blocks parasite multiplication and induces peptide-blocking antibodies. Infect Immun (1998) 0.90

Electroshock for atrial flutter and atrial fibrillation. Follow-up studies on 50 patients. JAMA (1965) 0.90

Effects of antiphagocytic agents on penetration of Eimeria magna sporozoites into cultured cells. J Parasitol (1976) 0.90

Tumor necrosis factor does not induce Plasmodium falciparum crisis forms. Infect Immun (1987) 0.90

Reactivity profile of human anti-82-kilodalton rhoptry protein antibodies generated during natural infection with Plasmodium falciparum. Infect Immun (1993) 0.89

Characteristics of chloroquine binding to glass and plastic. Am J Trop Med Hyg (1983) 0.89

Drug response and genetic characterization of Plasmodium falciparum clones recently isolated from a Sudanese village. Trans R Soc Trop Med Hyg (1993) 0.89

Seasonal changes in cell mediated immune responses to soluble Plasmodium falciparum antigens in children with haemoglobin AA and haemoglobin AS. Trans R Soc Trop Med Hyg (1992) 0.88

A functional amino acid substitution in the glucose-dependent insulinotropic polypeptide receptor (GIPR) gene is associated with lower bone mineral density and increased fracture risk. J Clin Endocrinol Metab (2014) 0.88

Depression and symptoms of attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry (1988) 0.87

Synthesis and evaluation of 1-acyl-1,2-bis(methylsulfonyl)-2-(2- chloroethyl)hydrazines as antineoplastic agents. J Med Chem (1993) 0.87

Modulation of the cellular immune response during Plasmodium falciparum infections in sickle cell trait individuals. Clin Exp Immunol (1992) 0.87

Uptake of antibiotics by Plasmodium falciparum in culture. Am J Trop Med Hyg (1988) 0.87

Clindamycin for the treatment of falciparum malaria in Sudan. Am J Trop Med Hyg (1985) 0.86

Effect of calmodulin inhibitors on viability and mitochondrial potential of Plasmodium falciparum in culture. Antimicrob Agents Chemother (1986) 0.86

Total anomalous pulmonary venous return. A review and report of the oldest surviving patient. Am Heart J (1971) 0.86

Some aspects of serum requirements for continuous cultivation of Plasmodium falciparum. Bull World Health Organ (1979) 0.86

Identification and partial characterization of exoantigens derived from medium used to culture Plasmodium falciparum. Am J Trop Med Hyg (1983) 0.85

Nutritional requirements of Plasmodium falciparum in culture. II. Effects of antimetabolites in a semi-defined medium. J Protozool (1985) 0.85

The dexamethasone suppression test in infantile autism. J Am Acad Child Psychiatry (1985) 0.84

Some recent advances in the cultivation of Plasmodium falciparum. Isr J Med Sci (1978) 0.84

Methylating agents as trypanocides. J Med Chem (1990) 0.84

Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei. Am J Trop Med Hyg (1993) 0.84

Cell-mediated immune responses to soluble Plasmodium falciparum antigens in residents from an area of unstable malaria transmission in the Sudan. APMIS (1990) 0.83

Human T-cell recognition of synthetic peptides representing conserved and variant sequences from the merozoite surface protein 2 of Plasmodium falciparum. Immunol Lett (1997) 0.83

The effects of the methylating agent 1,2-bis(methylsulfonyl)-1-methylhydrazine on morphology, DNA content and mitochondrial function of Trypanosoma brucei subspecies. J Protozool (1991) 0.83

Inhibition of the growth of Plasmodium falciparum in vitro by covalent modification of hemoglobin. Mol Biochem Parasitol (1983) 0.82

Activity of azithromycin (CP-62,993) and erythromycin against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. Am J Trop Med Hyg (1992) 0.82

Storage requirements for erythrocytes used to culture Plasmodium falciparum. J Parasitol (1983) 0.82

Renal tubular acidosis following intestinal bypass: an etiological study. Int J Obes (1984) 0.81

Affinity-purified antibodies to ring-infected erythrocyte surface antigen do not correlate with merozoite invasion inhibition in Plasmodium falciparum. Infect Immun (1988) 0.81

Studies on serum requirements for the cultivation of Plasmodium falciparum. 2. Medium enrichment. Bull World Health Organ (1982) 0.81

Reduced cellular immune reactivity in healthy individuals during the malaria transmission season. Immunol Lett (1990) 0.81

Elimination of oral cimetidine in chronic renal failure and during haemodialysis. Br J Clin Pharmacol (1980) 0.81

Lymphoproliferative responses to Plasmodium falciparum antigens in children with and without the sickle cell trait. Scand J Immunol (1991) 0.81

Effects of combinations of quinoline-containing antimalarials on Plasmodium falciparum in culture. Ann Trop Med Parasitol (1986) 0.80

Isolation and cultivation of Plasmodium falciparum using adult bovine serum. J Parasitol (1985) 0.80